Literature DB >> 19534258

Searching for safety: addressing search engine, website, and provider accountability for illicit online drug sales.

Bryan A Liang1, Tim Mackey.   

Abstract

Online sales of pharmaceuticals are a rapidly growing phenomenon. Yet despite the dangers of purchasing drugs over the Internet, sales continue to escalate. These dangers include patient harm from fake or tainted drugs, lack of clinical oversight, and financial loss. Patients, and in particular vulnerable groups such as seniors and minorities, purchase drugs online either naïvely or because they lack the ability to access medications from other sources due to price considerations. Unfortunately, high risk online drug sources dominate the Internet, and virtually no accountability exists to ensure safety of purchased products. Importantly, search engines such as Google, Yahoo, and MSN, although purportedly requiring "verification" of Internet drug sellers using PharmacyChecker.com requirements, actually allow and profit from illicit drug sales from unverified websites. These search engines are not held accountable for facilitating clearly illegal activities. Both website drug seller anonymity and unethical physicians approving or writing prescriptions without seeing the patient contribute to rampant illegal online drug sales. Efforts in this country and around the world to stem the tide of these sales have had extremely limited effectiveness. Unfortunately, current congressional proposals are fractionated and do not address the key issues of demand by vulnerable patient populations, search engine accountability, and the ease with which financial transactions can be consummated to promote illegal online sales. To deal with the social scourge of illicit online drug sales, this article proposes a comprehensive statutory solution that creates a no-cost/low-cost national Drug Access Program to break the chain of demand from vulnerable patient populations and illicit online sellers, makes all Internet drug sales illegal unless the Internet pharmacy is licensed through a national Internet pharmacy licensing program, prohibits financial transactions for illegal online drug sales, and establishes criminal penalties for all parties -- including websites, search engines, and health care providers -- who engage in and facilitate this harmful activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19534258     DOI: 10.1177/009885880903500104

Source DB:  PubMed          Journal:  Am J Law Med        ISSN: 0098-8588


  29 in total

1.  Implications of Internet availability of genomic information for public health practice.

Authors:  B W Hesse; N K Arora; M J Khoury
Journal:  Public Health Genomics       Date:  2012-04-04       Impact factor: 2.000

2.  Identification and evaluation of drug-supplement interactions in Hungarian hospital patients.

Authors:  Anna Végh; Erzsébet Lankó; András Fittler; Róbert György Vida; Ildikó Miseta; Gábor Takács; Lajos Botz
Journal:  Int J Clin Pharm       Date:  2014-02-23

3.  Online, direct-to-consumer access to insulin: patient safety considerations and reform.

Authors:  Kimberly M Lovett; Bryan A Liang; Timothy K Mackey
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

4.  Oncology and the Internet: regulatory failure and reform.

Authors:  Tim K Mackey; Bryan A Liang
Journal:  J Oncol Pract       Date:  2012-07-24       Impact factor: 3.840

Review 5.  Digital danger: a review of the global public health, patient safety and cybersecurity threats posed by illicit online pharmacies.

Authors:  Tim K Mackey; Gaurvika Nayyar
Journal:  Br Med Bull       Date:  2016-05-05       Impact factor: 4.291

6.  Illicit Internet availability of drugs subject to recall and patient safety consequences.

Authors:  Tim K Mackey; Phyo Aung; Bryan A Liang
Journal:  Int J Clin Pharm       Date:  2015-07-07

7.  Twitter-Based Detection of Illegal Online Sale of Prescription Opioid.

Authors:  Tim K Mackey; Janani Kalyanam; Takeo Katsuki; Gert Lanckriet
Journal:  Am J Public Health       Date:  2017-10-19       Impact factor: 9.308

Review 8.  After counterfeit Avastin®--what have we learned and what can be done?

Authors:  Tim K Mackey; Raphael Cuomo; Camille Guerra; Bryan A Liang
Journal:  Nat Rev Clin Oncol       Date:  2015-03-03       Impact factor: 66.675

9.  Availability of buprenorphine on the Internet for purchase without a prescription.

Authors:  Marcus A Bachhuber; Chinazo O Cunningham
Journal:  Drug Alcohol Depend       Date:  2012-11-30       Impact factor: 4.492

10.  Global reach of direct-to-consumer advertising using social media for illicit online drug sales.

Authors:  Tim Ken Mackey; Bryan A Liang
Journal:  J Med Internet Res       Date:  2013-05-29       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.